Aim: To evaluate the association of altered lipid levels and development of adverse maternal and fetal outcomes.
Materials and methods: Women attending outpatient department (OPD), antenatal care (ANC) and in patient department (IPD) of the Department of Obstetrics and Gynecology, Jawaharlal Nehru Medical College, Hospital, Aligarh Muslim University, Aligarh, were included in this study after obtaining informed consent and ethical approval from the institute.
Results: Mean age of pregnant women in the study group was 24.89 ± 3.12 years, whereas in the control group, it was 24.72 ± 3.76 years. Mean prepregnancy weight was 51–55 kg in both study and control groups. Mean BMI of the pregnant women in the study group was 21.89 ± 1.89 kg/m2, whereas in the control group, it was 21.52 ± 1.47 kg/m2. The levels of total cholesterol, triglycerides (TG), low density lipoprotein (LDL) and VLDL were significantly high in women who developed gestational diabetes mellitus (GDM) when compared to those who did not develop GDM and the difference was found to be statistically significant (p <0.001). The levels of total cholesterol, TG, and VLDL were significantly high in women who developed preeclampsia as compared to the women who did not develop preeclampsia (p <0.05). The levels of total cholesterol, TG, LDL and VLDL in women who developed preterm labor were found to be significantly high in women who developed preterm labor (p <0.01) as compared to women who did not have PTL. The levels of total cholesterol, TG, LDL, and VLDL in women who developed intrahepatic cholestasis of pregnancy (IHCP) were statistically significant when the two groups were compared (p <0.001). The levels of total cholesterol, TG, LDL, VLDL, in women who developed macrosomia were not statistically significant when the two groups were compared (p >0.05). Women who developed small for gestational age (SGA) had statistically significant high levels of total cholesterol, TG, LDL, and VLDL (p <0.05).
Conclusions: The present cohort study was undertaken in the north Indian population to explore the association between dyslipidemia in pregnancy and its adverse maternal and fetal outcomes. It was seen that third trimester maternal dyslipidemia is associated with various maternal and fetal complications such as gestational diabetes mellitus, preeclampsia, IHCP, preterm labor, and SGA babies.
Singh A, Kujur A, Jain P. Feta-maternal impact of altered lipid profile in pregnancy. Int J Reprod Contracept Obstet Gynecol 2017;7(1):132. DOI: 10.18203/2320-1770.ijrcog20175547.
Vrijkotte TG, Krukziener N, Hutten BA, et al. Maternal lipid profile during early pregnancy and pregnancy complications and outcomes: the ABCD study. J Clin Endocrinol Metab 2012;97(11):3917–3925. DOI: 10.1210/jc.2012-1295.
Maurkiewicz JC, Watts GF, Warburton FG, et al. Serum lipids, lipoproteins and apolipoproteins in pregnant non-diabetic patients. J Clin Pathol 1994;47(8):728–731. DOI: 10.1136/jcp.47.8.728.
Sattar N, Greer IA, Louden J, et al. Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein. J Clin Endocrinol Metan 1997;82(4):2483–2491. DOI: 10.1210/jcem.82.8.4126.
Oguru K, Miyatake T, Fakui O, et al. Low density lipoprotein particle diameter in normal pregnancy and preeclampsia. J Atheroscler Thromb 2002;9(5):42–47. DOI: 10.5551/jat.9.42.
Catov JM, Ness RB, Wellons MF, et al. Prepregnancy lipid related to preterm birth risk: the coronary artery risk development in young adults study. J Clin Endocrinol Metab 2010;95(6):3711–3718. DOI: 10.1210/jc.2009-2028.
Jan MR, Nazli R, Shah J, et al. A study of lipoprotein in normal and pregnancy induced hypertensive women in tertiary care hospitals of the North West Frontier Province-Pakistan. Hypertensive Pregnancy 2012;31(7):292–299 [Bibliography 93]. DOI: 10.3109/10641955.2010.507843.
Ziaei S, Bonab KM, Kazemnejad A. Serum lipid levels at 28–32 weeks gestation and hypertensive disorders. Hypertens Pregnancy 2006;25(8):3–10. DOI: 10.1080/10641950500543756.
Di Cianni G, Miccoli R, Volpe L, et al. Maternal triglyceride levels levels and newborn weight in prepregnant women with normal glucose tolerance. Diabet Med 2005;22(9):21–25. DOI: 10.1111/j.1464-5491.2004.01336.x.
Kitajima, Oka S, Yasuhi I, et al. Maternal serum triglycerides 24–36 weeks gestation and newborn weight in nondiabetic women with positive diabetic screens. Obstet Gynecol 2001;97(10):776–780. DOI: 10.1016/s0029-7844(01)01328-x.
Kushtagi P, Arvapally S. Maternal mid pregnancy serum TAG and neonatal birth weight. Int J Gynaecol Obstet 2009;106(11):258–259. DOI: 10.1016/j.ijgo.2009.03.004.
Edison RJ, Berg K, Remaley A, et al. Adverse birth outcome among mothers with low serum cholesterol. Pediatrics 2007;120(12):723–733. DOI: 10.1542/peds.2006-1939.
Sattar N, Greer IA, Galloway PJ, et al. Lipid and lipoprotein concentrations in pregnancies complicated by intra uterine growth restriction. J Clin Endocrinol Metab 1999;84(13):128–130. DOI: 10.1210/jcem.84.1.5419.
Jin WY, Lin SL, Hou RL, et al. Associations between maternal lipid profile and pregnancy complications and perinatal outcomes: a population-based study from China. BMC Pregnancy Childbirth 2016;16:60. DOI: 10.1186/s12884-016-0852.
Helmy MA, El-Latif EMA, Mohamed MF, et al. Relation between maternal lipid profile and pregnancy complications and perinatal outcomes. AIMJ 2020;1(11):179. DOI: 10.21608/aimj.2021. 46596.1337.
Sharami SH, Abbasi Ranjbar Z, Alizadeh F, et al. The relationship of hyperlipidemia with maternal and neonatal outcomes in pregnancy: a cross sectional study. Int J Reprod BioMed 2019;17:739–748. DOI: 10.18502/ijrm.v17i10.529.
Anuradha R, Durga T. Estimation of lipid profile among preeclampsia woman by comparing with normal pregnancy. Int J Contemporary Med Res 2016;3(7):1958–1961. https://dx.doi.org/10.18203/2320-1770.ijrcog20195348.
Shen H, Liu X, Chen Y, et al. Associations of lipid levels during gestation with hypertensive disorders of pregnancy and gestational diabetes mellitus: a prospective longitudinal cohort study. BMJ Open 2016;6:e013509. DOI: 10.1136/bmjopen-2016-013509.